Medicines to Prevent Respiratory Syncytial Virus (RSV) Infection
Preventive medicines are usually used only for babies and
children who have a higher risk of having complications if they become infected
respiratory syncytial virus (RSV). These medicines are
not used to treat someone who already has RSV infection.
Palivizumab (Synagis) is a medicine containing laboratory-produced
antibodies designed to help prevent RSV infections. RSV infections that develop
despite being given this medicine are usually less severe. Palivizumab is given
by injection into the muscle (intramuscular, or IM) once a month during the
No standard preventive
immunization exists because there is more than one
type of RSV and many subtypes (strains). Researchers are trying to develop a
vaccine that is effective for the general population at a reasonable
How this information was developed to help you make better health decisions.